Regulatory Science 606:

Regulation of Emerging Technologies and Biological Products (3.0 units)

Policies, testing and regulatory requirements affecting commercialization of biologics and novel medical technologies. Focus on biologics, blood and tissue products, radiopharmaceuticals and nanotechnology
    49141D626LectureTBATBA17 of 50Frances Richmond,
    Eunjoo Pacifici,Michael Jamieson
    OFFICEsession dates
    Information accurate as of March 4, 2018 5:28 pm.
    Did you find what you needed today? Let us know by taking a short survey.